ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 74 filers reported holding ADMA BIOLOGICS INC in Q3 2019. The put-call ratio across all filers is 3.79 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $18,000 | +200.0% | 10,000 | +412.8% | 0.00% | – |
| Q2 2020 | $6,000 | -87.5% | 1,950 | -88.3% | 0.00% | -100.0% |
| Q1 2020 | $48,000 | -27.3% | 16,597 | +0.5% | 0.00% | 0.0% |
| Q4 2019 | $66,000 | -10.8% | 16,519 | +0.1% | 0.00% | 0.0% |
| Q3 2019 | $74,000 | +10.4% | 16,500 | -6.0% | 0.00% | 0.0% |
| Q2 2019 | $67,000 | +13.6% | 17,545 | +13.2% | 0.00% | 0.0% |
| Q1 2019 | $59,000 | +68.6% | 15,500 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $35,000 | -55.7% | 15,500 | +21.1% | 0.00% | -50.0% |
| Q3 2018 | $79,000 | -66.4% | 12,800 | -75.4% | 0.00% | -50.0% |
| Q2 2018 | $235,000 | – | 52,091 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $6,464,000 | 99.88% |
| Broadfin Capital, LLC | 3,249,829 | $14,657,000 | 2.31% |
| Stonepine Capital Management, LLC | 831,731 | $3,751,000 | 2.28% |
| Aisling Capital LLC | 3,608,171 | $16,273,000 | 2.14% |
| Consonance Capital Management LP | 4,249,234 | $19,164,000 | 1.24% |
| MORGENS WATERFALL VINTIADIS & CO INC | 375,000 | $1,691,000 | 1.20% |
| Perceptive Advisors | 6,521,102 | $29,410,000 | 0.77% |
| PURA VIDA INVESTMENTS, LLC | 325,000 | $1,466,000 | 0.59% |
| 683 Capital Management, LLC | 885,000 | $3,991,000 | 0.27% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $361,000 | 0.05% |